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Abstract
The influenza B virus BM2 protein contains 109 amino acid residues and it is translated from a bicistronic mRNA in an open reading
frame that is 2 nucleotides with respect to the matrix (M1) protein. The amino acid sequence of BM2 contains a hydrophobic region
(residues 7–25) that could act as a transmembrane (TM) anchor. Analysis of properties of the BM2 protein, including detergent solubility,
insolubility in alkali pH 11, flotation in membrane fractions, and epitope-tagging immunocytochemistry, indicates BM2 protein is the fourth
integral membrane protein encoded by influenza B virus in addition to hemagglutinin (HA), neuraminidase (NA), and the NB glycoprotein.
Biochemical analysis indicates that the BM2 protein adopts an NoutCin orientation in membranes and fluorescence microscopy indicates
BM2 is expressed at the cell surface. As the BM2 protein possesses only a single hydrophobic domain and lacks a cleavable signal sequence,
it is another example of a Type III integral membrane protein, in addition to M2, NB, and CM2 proteins of influenza A, B, and C viruses,
respectively. Chemical cross-linking studies indicate that the BM2 protein is oligomeric, most likely a tetramer. Comparison of the amino
acid sequence of the TM domain of the BM2 protein with the sequence of the TM domain of the proton-selective ion channel M2 protein
of influenza A virus is intriguing as M2 protein residues critical for ion selectivity/activation and channel gating (H37 and W41, respectively)
are found at the same relative position and spacing in the BM2 protein (H19 and W23).
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The Orthomyxoviridae family of viruses includes the
genera Influenzavirus A and Influenzavirus B. Human in-
fluenza A virus was first isolated in 1933 (Smith et al.,
1933), and in 1940 Francis (1940) detected a new type of
influenza virus that had no antigenic relationship to influ-
enza A virus which was called type B (Horsfall et al., 1940).
Influenza B virus, unlike influenza A virus, does not un-
dergo periodic major antigenic shifts in its major surface
glycoproteins, hemagglutinin (HA) and neuraminidase
(NA). In part this may be due to the inability of influenza B
virus to undergo genetic reassortment with influenza A virus
(Compans and Choppin, 1975) coupled with the absence of
an animal reservoir for influenza B virus (Kilbourne, 1975).
Morphologically, influenza A and B viruses are very simi-
lar, both exhibiting pleomorphic enveloped particles with
surface glycoprotein spike projections.
At the biochemical level, influenza A and B viruses both
have negative-stranded RNA genomes consisting of eight
RNA segments. For influenza B virus the genome chain
length totals 14,639 nucleotides, whereas for influenza A
virus (A/PR/8/34) the genome totals 13,588 nucleotides.
The difference in genome size is largely due to the fact that
the 5 and 3 untranslated regions of influenza B virus are
longer than those of influenza A virus. For both influenza A
and B viruses RNA segments 1–3 encode the three poly-
merase proteins, PB1, PB2, and PA, RNA segment 4 en-
codes HA; RNA segment 5 encodes the nucleocapsid pro-
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tein (NP); RNA segment 6 encodes NA; RNA segment 7
encodes the matrix protein (M1) and RNA segment 8 en-
codes two proteins NS1 and NEP that are translated from
unspliced and spliced mRNAs using overlapping reading
frames (reviewed in Lamb and Krug, 2001).
Despite these genome RNA segment coding similarities
for proteins with similar functional properties, the genomes
of influenza A and B viruses also differ in coding for
additional proteins that distinguish the influenza A and B
virus types. Most strains of influenza A virus (but not all)
encode on RNA segment 2, using an overlapping reading
frame, an 87 residue protein called PB1-F2, and the avail-
able evidence suggests PB1-F2 is involved in virus-induced
apoptosis (Chen et al., 2001). For all influenza A viruses
RNA segment 7, in addition to encoding the M1 protein,
also encodes the M2 integral membrane protein (Lamb and
Choppin, 1981; Lamb et al., 1985). The M1 and M2 proteins
are translated from unspliced and spliced mRNAs, respec-
tively, using overlapping reading frames (Lamb et al.,
1981). The influenza B virus genome encodes two extra
proteins. Influenza B virus RNA segment 6, in addition to
coding for the B/NA protein, also encodes via a bicistronic
mRNA and by using an overlapping reading frame the 100
residue NB glycoprotein (Shaw et al., 1983). Initiation of
translation of NB occurs using an AUG codon positioned
four nucleotides before the AUG codon used to initiate the
NA protein (Williams and Lamb, 1989). Influenza B virus
RNA segment 7 in addition to encoding the M1 protein
encodes the BM2 protein (Horvath et al., 1990).
The influenza B virus BM2 protein is translated from an
open reading frame that is 2 nucleotides with respect to
the reading frame of the M1 protein and it is conserved in all
isolates of influenza B virus. The BM2 protein contains 109
residues and in influenza B virus-infected cells the BM2
protein has an apparent Mr of 12–15 kDa (Horvath et al.,
1990). A mutational analysis indicates that the BM2 protein
initiation codon overlaps with the termination codon of the
M1 protein in a translational stop-start pentanucleotide
UAAUG and that expression of the BM2 protein requires
termination of M1 synthesis adjacent to the 5 end of the
BM2 coding region; thus, termination of translation and the
reinitiation event are tightly coupled (Horvath et al., 1990).
Further characterization of the BM2 protein by Odagiri and
co-workers indicates that it is posttranslationally modified
by phosphorylation, that BM2 is incorporated into purified
virions, and that the BM2 protein is localized to the cyto-
plasm (Odagiri et al., 1999).
When we examined the amino acid sequence of the BM2
protein using several protein prediction algorithms, we ob-
served that BM2 residues 7–25 (ILSICSFILSALHF-
MAWTI) formed a hydrophobic domain that could act as a
transmembrane (TM) segment. We report here the results of
cell biology experiments that indicated the BM2 protein has
properties expected of an integral membrane protein and
that BM2 is expressed at the surface of virus-infected cells
with an NoutCin orientation.
Results
Influenza B virus BM2 protein has properties of an
integral membrane protein
The expression in MDCK cells of the influenza B virus
BM2 protein by various influenza B virus strains was con-
firmed by immunoprecipitating [35S]methionine/cysteine-
labeled cell lysates with rabbit antisera (anti-BM2) gener-
ated to a -galactosidase–BM2 open reading frame fusion
protein (Horvath et al., 1990). As shown in Fig. 1, BM2
(Mr  15 kDa) was immunoprecipitated from virus-infected
cells. BM2 protein exhibited strain-specific electrophoretic
mobility differences which probably reflect amino acid se-
quence differences among influenza B virus BM2 proteins
(approximately 85% conservation of sequence from
B/Lee/40 (Briedis et al., 1982) to B/Shiga/98 (Lindstrom et
al., 1999)). The multiple bands observed for B/Sing/79
BM2 may represent breakdown products of BM2. Although
the anti-BM2 sera precipitated nonspecifically some other
proteins, the sera was judged suitable for further analysis of
the BM2 protein. Influenza B/MD/59 virus was selected as
a virus strain for investigation of properties of the BM2
protein.
To test whether the BM2 protein had properties expected
Fig. 1. Synthesis of BM2 protein in influenza B virus-infected cells.
MDCK cells were infected with various strains of influenza B virus at a
multiplicity of infection of 5 PFU per cell. At 7 h postinfection cells were
metabolically labeled with Pro-mix L[35S] in vitro cell-labeling mix (150
Ci/ml) in DMEM MetCys for 2 h. Cells were lysed in RIPA buffer;
lysates were immunoprecipitated with anti-BM2 sera and polypeptides
were analyzed by SDS–PAGE on a 17.5% acrylamide gel containing 4 M
urea. The strains of influenza B virus used are indicated. Uninf  unin-
fected cell lysate.
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of an integral membrane protein, a postnuclear supernatant
from [35S]methionine/cysteine metabolically labeled virus-
infected cells was treated with detergent and high salt con-
centrations and was separated by centrifugation (150,000 g
for 30 min) into a pellet and supernatant and aliquots were
immunoprecipitated with HA (a known integral membrane
protein) antisera or BM2 antisera. As shown in Fig. 2A, the
solubility properties of BM2 paralleled those of HA in that
neither protein was soluble after 0.5 M NaCl treatment; both
HA and BM2 were soluble after 2% Triton X-100 treatment
but the greatest extent of solubility was obtained after a
combined treatment of 0.5 M NaCl and 2% Triton X-100.
Another test to show that a protein is an integral membrane
protein as compared to a peripherally associated membrane
protein is to examine the solubility of the protein after pH
11.5 “alkali” treatment (Steck and Yu, 1973). As shown in
Fig. 2B, after alkali treatment of a microsomal fraction
derived from [35S]methionine/cysteine metabolically la-
beled virus-infected MDCK cells, the BM2 protein was
found predominantly in the pellet fraction, indicative that
BM2 is an integral membrane protein. To show further that
BM2 had properties expected of an integral membrane pro-
tein, a [35S]methionine/cysteine metabolically labeled post-
nuclear supernatant derived from virus-infected MDCK
cells was subjected to flotation centrifugation on Optiprep
gradients (Lindwasser and Resh, 2001). As shown in Fig.
2C, regardless of the precise subcellular origin of each
fraction, the bulk of HA and virtually all of BM2 were
found in fractions of a density of 1.058 to 1.163 as expected
for proteins associated with membrane fractions.
Determination using biochemistry that BM2 adopts an
NoutCin orientation in membranes
The determination of the orientation of an integral mem-
brane protein is facilitated by obtaining site-specific antisera
to the N-terminal and C-terminal sides of the TM domain(s)
(Lamb et al., 1985). However, for the BM2 protein the
precise boundaries of the single BM2 TM domain are not
known. Furthermore, the determination of the BM2 protein
orientation is confounded by the fact that the number of
N-terminal residues preceding the TM domain is small,
likely ranging from four to seven residues. Thus, we re-
sorted to surrogate markers to examine the orientation of
BM2 in membranes and to infer the expression of BM2 at
the cell surface. To provide an N-terminal domain marker
we substituted the first four residues of BM2 (MLEP)
with 25 residues (M2g) (MSNLTEVETPIRNEWGCRC-
NDSSNP) derived from the ectodomain of a modified in-
fluenza A virus M2 protein and we designated this protein
M2gBM2 (Fig. 3A). The M2g domain provides a site for
addition of N-linked carbohydrate (NLT), which we have
shown previously is used in another protein, gM2 (Sakagu-
chi et al., 1996), and the M2g domain provides the epitope
for the 14C2 M2-specific monoclonal antibody (MAb)
(M2Tag). To provide a C-terminal marker the epitope
Fig. 2. BM2 protein has properties of an integral membrane protein. (A)
Influenza B virus-infected MDCK cells were metabolically labeled as
described in the legend to Fig. 1. A postnuclear supernatant was
subjected to no treatment, 2% Triton X-100 treatment, 0.5 M NaCl
treatment, or 0.5 M NaCl plus 2% Triton X-100 treatment. Pellet and
supernatant fractions were made as described under Materials and
Methods and proteins were immunoprecipitated with anti-HA sera or
anti-BM2 sera. Polypeptides were analyzed by SDS–PAGE on a 17.5%
acrylamide gel containing 4 M urea. P  pellet; S  supernatant. (B)
The BM2 protein is resistant to extraction from microsomal membranes
with alkali pH 11.5. Microsomes from metabolically labeled influenza
B virus-infected cells were prepared and a pH 11.5 extraction per-
formed. P  pellet; S  supernatant; M  marker polypeptides. (C)
The BM2 protein is associated with the membrane fraction of cells. A
cell homogenate from influenza B virus-infected MDCK cells (as
above) was subjected to flotation centrifugation on Optiprep gradients.
Nine fractions were collected and immunoprecipitated with anti-HA
and anti-BM2 sera.
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(DYKDDDDK) for the Flag MAb was added to the C-
terminus of BM2 (BM2Flag) (Fig. 3A). The orientation of
virtually all natural integral membrane proteins is absolute.
However, for the artificial M2gBM2 protein a caveat that
has to be considered is that because the region bordering the
BM2 TM domain has been altered the chimeric molecule
might adopt more than one orientation as observed in other
artificial membrane proteins (Parks and Lamb, 1991, 1993).
The addition of the Flag tag to the BM2 C-terminus is
considered most unlikely to alter the BM2 orientation in
membranes because it is located 84 residues distal from the
TM domain. It is interactions of the TM domain with the
endoplasmic reticulum translocation machinery that specify
orientations.
BM2, M2gBM2, and BM2Flag were transiently ex-
pressed using a pCAGGS expression vector (Niwa et al.,
1991) in 293T cells and cell lysates immunoprecipitated
with anti-BM2 sera, MAb 14C2 (Zebedee et al., 1985)
(anti-M2tag), or a MAb to the Flag epitope (anti-Flag). As
shown in Fig. 3B the BM2Flag protein had a gel mobility
consistent with addition of eight residues to its C terminus
(Mr  17 kDa). Three major species of M2gBM2 were
observed after precipitation with either the BM2 sera or the
M2tag sera (Fig. 3). The fastest migrating band had a gel
mobility consistent with an unglycosylated M2gBM2 spe-
cies (Mr  18 kDa); the middle band (designated
gM2gBM2) had a mobility consistent with addition of an
N-linked carbohydrate chain to the protein (Mr  22 kDa)
and the third species was a “swarm” of heterogeneously
migrating protein, designated pL (Mr  22–30 kDa). We
have shown previously for the related gM2 protein which
contains the M2 ectodomain and glycosylation site that it
migrates on SDS–PAGE as a heterogeneously migrating
Fig. 3. Transient expression of BM2, M2gBM2, and BM2-Flag to deter-
mine the orientation of BM2 in membranes. (A) Schematic diagram to
illustrate the recombinant DNA molecules constructed. M2gBM2 has the
first four residues of BM2 (MLEP) substituted with 25 residues (MSNLTE-
VETPIRNEWGCRCNDSSNP) derived from the ectodomain of a modified
influenza A virus M2 protein (M2g). The M2g domain provides a site for
addition of N-linked carbohydrate (NLT) and provides the epitope for the
14C2 M2-specific monoclonal antibody (MAb) (M2Tag). BM2Flag con-
tains the epitope (DYKDDDDK) for the Flag MAb added to the C-
terminus of BM2. TMD  transmembrane domain; CHO  N-linked
carbohydrate chain. (B) BM2, M2gBM2, and BM2-Flag were transiently
expressed using the pCAGGS expression vector in 293T cells. At 18 h
posttransfection cells were metabolically labeled with Pro-mix L[35S] in
vitro cell labeling mix (150 Ci/ml) in DMEM MetCys for 2 h. Cells
were lysed and protein was immunoprecipitated with anti-BM2 sera, anti-
M2Tag, or anti-Flag sera; polypeptides were subjected to electrophoresis
on SDS–PAGE. Un  mock empty vector transfected cell lysate; pL 
heterogeneously migrating gM2gBM2 species. (C) Protease treatment of
microsomes. M2gBM2, BM2-Flag, and influenza A virus M2 protein were
transiently expressed in HeLa-CD4-LTR--gal cells and metabolically
labeled as described above. A crude microsomal fraction was prepared and
aliquots treated with trypsin or 1% Nonidet P-40  trypsin as described
under Materials and Methods. Microsomes were pelleted through a sucrose
cushion, lysed, and immunoprecipitated with appropriate antisera as indi-
cated. U  untreated microsomes; T  microsomes digested with trypsin;
Dmicrosomes digested with trypsin in the presence of 1% Nonidet P-40;
N-tM2  protease protected ectodomain and TM domain of influenza A
virus M2 protein; N-tgM2gBM2  protease protected ectodomain and TM
domain of gM2gBM2; N-tM2gBM2  protease protected ectodomain and
TM domain of M2gBM2; Asterisk  protease protected cytoplasmic tail
and TM domain of M2gBM2; pL heterogeneously migrating gM2gBM2
species; M  marker polypeptides.
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protein and this is due to a polylactosaminoglycan addition
to the high mannose carbohydrate chain (Sakaguchi et al.,
1996), a modification which occurs in the Golgi apparatus.
Species of greater mass (indicated by asterisks; Mr 44–70
kDa) were also observed on occasion and these species may
represent an SDS-resistant oligomer (dimer) of gM2gBM2
(Fig. 3B). A pulse-label and chase protocol indicated that
the M2gBM2 species largely converted to gM2gBM2 and
after a 90-min chase period, 80% of M2gBM2 was observed
as the heterogeneously migrating protein (data not shown).
These data suggest that the N-terminal domain that is mod-
ified by carbohydrate addition and recognized by the N-
terminal specific M2tag antibody is lumenal.
To provide evidence that BM2 protein has a cytoplasmic
tail and to further corroborate the orientation of BM2 in mem-
branes, a crude preparation of microsomes from [35S]metaboli-
cally labeled BM2Flag, M2gBM2, and influenza A virus M2-
expressing HeLa-CD4-LTR--gal cells was isolated, treated
with trypsin, and pelleted through a sucrose gradient. A caveat
that has to be added concerning the interpretation of these
experiments is that due to the method of preparing microsomal
membranes, a small percentage of vesicles reseal in their non-
native orientation (Zebedee, 1988). As shown in Fig. 3C di-
gestion with trypsin of microsomes expressing influenza A
virus M2 protein and immunoprecipitation with the M2tag
antisera yielded a protease protected N-terminal fragment of
7.5 kDa as demonstrated previously (Zebedee et al., 1985).
Essentially all M2-related species were lost on trypsin treat-
ment in the presence of 1% Nonidet P-40. Digestion of micro-
somes expressing BM2Flag with trypsin caused a loss of 91%
of the radioactivity in the BM2Flag band when immunopre-
cipitated with either the anti-Flag or the anti-BM2 sera, a
finding consistent with the large majority of BM2Flag mole-
cules having 84 C-terminal residues residing in the cyto-
plasm. Digestion of microsomes expressing M2gBM2 with
trypsin and immunoprecipitation with the N-terminal-specific
M2 tag antisera yielded protease-resistant fragments of 13 kDa
(N-tgM2gBM2) and 8 kDa (N-tM2gBM2), masses consistent
with these fragments containing the glycosylated and ungly-
cosylated gM2 ectodomain and the BM2 TM domain. Immu-
noprecipitation of trypsin-treated M2gBM2-expressing micro-
somes with anti-BM2 sera yielded a small amount of a
fragment (Fig. 3C, asterisk) that is consistent with loss of the
gM2 domain and protection of the BM2 TM domain and
cytoplasmic tail and this species most likely represents vesicles
that resealed in the nonnative orientation. In all cases essen-
tially all BM2-related species were lost on trypsin treatment in
the presence of 1% Nonidet P-40. Taken together the biochem-
ical data indicated that the bulk of the BM2 molecules are
oriented in membranes in an NoutCin orientation.
BM2 is expressed at the cell surface
To examine the subcellular distribution of BM2 immu-
nofluorescence microscopy was performed on Vero and
HeLa CD4-LTR--gal cells that transiently expressed BM2,
M2gBM2, and BM2-Flag. The biochemical data shown
above indicates that BM2 largely adopts an NoutCin orien-
tation. Thus it can be predicted that fluorescence at the cell
surface would only be detected for cells expressing
M2gBM2 and staining with the M2tag antisera, whereas
neither BM2-Flag nor BM2 would be detected by surface
staining with the Flag-antisera or with the BM2 antisera,
respectively. Lack of detection of BM2 at the cell surface
with the BM2 antisera is predicted because an ectodomain
of four to seven residues is likely too small a region to
which an antibody would gain accessibility at the cell sur-
face even should such a region be an antigenic epitope in the
original SDS-denatured -galactosidase–BM2 fusion pro-
tein antigen. In contrast the M2tag antisera, the Flag anti-
sera, and the BM2 antisera would all be expected to show
fluorescent staining after permeabilization of the plasma
membrane with detergent. As shown in Fig. 4A for Vero
cells, M2gBM2 was detected at the cell surface after stain-
ing with M2tag antisera, whereas neither BM2-Flag nor
BM2 could be detected at the cell surface using anti-Flag
sera or anti-BM2 sera, respectively. In permeabilized cells
all three proteins could be detected with the antisera unique
for the expressed protein. In permeabilized cells, particu-
larly after staining with the M2tag or Flag antisera, the BM2
proteins showed extensive staining in a perinuclear region
of the cell, characteristic of Golgi staining (see, for example,
Hiebert et al., 1988; Sakaguchi et al., 1996; Zebedee et al.,
1985). It is also interesting to note that when the anti-BM2
sera was used for intracellular staining, the characteristic
Golgi staining pattern found when using the anti-M2Tag or
anti-Flag antibodies was not observed. This antisera was
raised against an SDS-denatured fusion protein. Although it
could be argued that BM2 is the native protein whereas
M2gBM2 and BM2-Flag are not native, the explanation for
the subtle staining difference that we prefer is that the
anti-BM2 sera only recognizes forms of BM2 in the endo-
plasmic reticulum and that the oligomerized (see below) and
properly folded oligomer present in the Golgi apparatus is
not well recognized by the BM2 antisera. Transient expres-
sion of M2gBM2 and BM2-Flag in the highly transfectable
HeLa CD4-LTR--gal cells (Fig. 4B) showed similar stain-
ing patterns as found in Vero cells. The BM2 sera was found
to give a high background in HeLa CD4-LTR--gal cells
and thus was not used. To provide positive data for the
expression of BM2-Flag at the cell surface, serial confocal
images in the X-Y plane of HeLa CD4-LTR--gal cells
transiently expressing BM2-Flag and M2gBM2 and, as a
control for a known surface protein, the influenza A virus
M2 protein (A/M2), were reconstructed in the Z-plane (top
to bottom of cell). To minimize the amount of intracellular
BM2 related proteins in subcellular compartments, trans-
fected cells were treated with cycloheximide (100 g/ml)
for 2 h prior to fixation to “chase” the cohort of newly
synthesized molecules through the exocytic pathway to the
cell surface. The M2gBM2 and A/M2 molecules were
stained at the cell surface using the M2tag antibody,
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Fig. 4. Specific immunofluorescent staining of BM2, M2gBM2, and BM2-Flag indicates BM2 adopts an NoutCin orientation in membranes. Eukarytotic
expression vectors expressing M2gBM2, BM2-Flag, BM2, and influenza A virus M2 protein were transfected into cells and at 18 h posttransfection cells were
fixed with 2% formaldehyde. For permeabilization (Perm.) cells were treated with 0.1% saponin. Cells were stained with primary antibodies as indicated.
(A) Vero cells expressing M2gBM2, BM2-Flag, or BM2. The secondary antibody used was FITC-conjugated donkey anti-mouse IgG secondary antibody
or FITC-conjugated goat anti-rabbit IgG secondary antibody as appropriate. (B) HeLa-CD4-LTR--gal cells expressing M2gBM2 or BM2-Flag. The
secondary antibody used was Alexa Fluor 488 conjugated goat anti-mouse IgG secondary antibody. (C) HeLa-CD4-LTR- gal cells expressing M2gBM2,
BM2-Flag, or A/M2 as in (B). Z-section reconstructions on serial 7 micron sections in the X-Y plane were calculated to show surface staining of the proteins.
whereas BM2-Flag was stained using the Flag antibody on
detergent permeabilized cells. As shown in Fig. 4C, the
Z-plane reconstructions showed that BM2-Flag was ex-
pressed at the cell surface.
Oligomeric form of BM2
Many integral membrane proteins form oligomers. Thus,
to examine if BM2 formed oligomers, cells transiently
expressing BM2Flag were 35S-metabolically-labeled, re-
moved from the culture dish, and treated with 0.2%
Nonidet P-40 containing various concentrations of the
bifunctional crosslinker 3,3-dithiobis(sulfosuccinimi-
dyl-propionate) (DTSSP) and polypeptides were exam-
ined by SDS–PAGE on 15% gels. As shown in Fig. 5, with
no added cross-linker BM2 migrated as an17-kDa species
and as observed in Fig. 3 a small amount of a 34 kDa was
observed and the mass of this species is consistent with that
of an SDS-resistant dimer. On treatment with DTSSP higher
oligomers of BM2 were observed (species 2–4) which are
of mass of 34, 51, and 68 kDa and thus these data suggest
the monomeric BM2 species forms covalent adducts that are
dimers, trimers, and tetramers of BM2. Therefore, the most
likely minimal native oligomeric form of BM2 is a tetramer.
It was also observed that crosslinking with DTSSP yielded
a ladder of four minor species of higher masses (85–136
kDa) (indicated by asterisks) consistent with cross-linking
of two tetramers (Fig. 5).
Discussion
The data reported here provide evidence that the influ-
enza B virus BM2 is an integral membrane protein that is
expressed at the cell surface. Similar to the influenza A virus
M2 protein (Lamb et al., 1985) and the influenza B virus NB
glycoprotein (Williams and Lamb, 1986), the available ev-
idence indicates that the vast majority, if not all, of the BM2
protein molecules adopt an NoutCin orientation. The M2,
NB, and BM2 proteins possess only a single hydrophobic
domain and lack a cleavable signal sequence and proteins
with these characteristics are classified as Type III integral
membrane proteins (von Heijne, 1988; von Heijne and
Gavel, 1988). Cross-linking studies suggest the most likely
minimal native oligomeric form of BM2 is a tetramer.
The influenza A virus M2 protein has a proton selective
ion channel activity that is the target of the antiviral drug
amantadine (Chizhmakov et al., 1996; Duff and Ashley,
1992; Lin and Schroeder, 2001; Mould et al., 2000a,b; Pinto
et al., 1992; Sugrue and Hay, 1991). The M2 proton channel
functions during uncoating of virions in endosomes permit-
ting protons to enter the virion and bringing about dissoci-
ation of protein–protein interactions, principally weakening
those between the M1 and nucleocapsid NP protein. In
addition, the M2 protein functions during its transport
through the exocytic pathway. There the M2 protein ion
channel activity causes equilibration of pH of the lumen of
the trans-Golgi network (TGN) with the cytoplasm (for
reviews, see Hay, 1992; Lamb et al., 1994). The function of
the BM2 protein in the life cycle of influenza B virus is
currently unknown. Because the M2, NB, and CM2 proteins
of influenza A, B, and C viruses, respectively, are all small
integral membrane proteins with the same orientation in
membranes (reviewed in Lamb and Krug, 2001), it has been
speculated by analogy to the known function of the influ-
enza A virus M2 protein that all these proteins have ion
channel activity. The data in this article show that BM2 is
the fourth integral membrane protein of influenza B virus, in
addition to HA, NA, and NB. Furthermore, BM2 has the
same membrane orientation as M2, NB, and CM2.
The mature influenza A virus M2 protein is a homotet-
ramer (Holsinger and Lamb, 1991; Sugrue and Hay, 1991)
of 96 residues and is oriented in membranes such that it has
23 N-terminal extracellular (or lumenal) residues, a 19 res-
idue TM domain, and a 54 residue cytoplasmic tail (Lamb
et al., 1985; Tobler et al., 1999). A considerable body of
experimental evidence indicates that this TM domain con-
stitutes the proteinaceous core (the channel pore) that allows
a flux of protons across the membrane. M2 protein TM
domain histidine 37 is essential for both ion selectivity and
Fig. 5. BM2 is an oligomer. HeLa-CD4-LTR--gal cells transiently ex-
pressing BM2Flag were 35S-metabolically labeled, removed from the cul-
ture dish, and treated with 0.2% Nonidet P-40 containing the bifunctional
crosslinker 3,3-dithiobis(sulfosuccinimidyl-propionate) (DTSSP) and
polypeptides were examined by SDS–PAGE on 15% gels. 0  no added
crosslinker; 200 and 100  200 and 100 M DTSSP.
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activation, the latter being caused by a low pH environment
(pHout) at the M2 N-terminal ectodomain residues (Pinto et
al., 1992; Wang et al., 1995). Furthermore, recent data
indicate that gating of the M2 ion channel is governed by a
single side chain at residue 41 of the TM domain and that
this property is mediated by an indole moiety (Tang et al.,
2002). Unlike many ion channels where the gate is formed
by a whole segment of a protein, the data suggested a model
of striking simplicity for the M2 ion channel protein, with
the side chain of tryptophan 41 blocking the pore of the
M2 channel when pHout is high and with this side chain
leaving the pore when pHout is low. Thus, the Trp41 side
chain acts as the gate that opens and closes the pore (Tang
et al., 2002).
If the amino acid sequence of the BM2 TM domain
region 7ILSICSFILSALHFMAWTI25 is modeled as an
-helix, then S9, S12, S16, H19, and W23 could all form the
same face of an -helix and thus these residues could
form the aqueous pore of an oligomeric ion channel.
Remarkably, the two key residues for activation and
gating (H37 and W41) in the M2 ion channel are found at
the same spacing HXXXW (H19 and W23) in the BM2
TM domain (Fig. 6). The demonstration that NB of in-
fluenza B virus when expressed in bacteria and reconsti-
tuted into planar membranes has an ion channel activity
(Fischer et al., 2001; Sunstrom et al., 1996) is subject to
artifacts (reviewed in Lamb and Pinto, 1997). Further-
more, the ion channel activity reported by Fischer and
co-workers (2001) was reported to be blocked by aman-
tadine (Fischer et al., 2001), yet amantadine does not
inhibit the replication of influenza B virus. Thus, it seems
possible that the BM2 protein will have an ion channel
activity and this awaits to be determined using electro-
physiological recordings. The very recently developed
influenza B virus-specific reverse genetics methodology
(Hoffman et al., 2002; Jackon et al., 2002) should help
toward determining if the BM2 protein is essential for the
replicative cycle of the virus.
Materials and methods
Cells and viruses
Vero, 293T, and MDCK cells were maintained in
DMEM with 10% fetal calf serum (FCS). HeLa CD4-LTR-
-gal cells were grown and maintained in DMEM supple-
mented with 10% fetal bovine serum, 200 g/ml G418
(Genetecin, Invitrogen Inc., San Diego, CA), and 100 g/ml
hygromycin B (Invitrogen). These cells were obtained
through the AIDS Research and Reference Reagent Pro-
gram, Division of AIDS, NIAID, NIH (HeLa-CD4-LTR--
gal from Dr. Michael Emerman). Stocks of influenza B
virus (strains B/MD/59, B/Singapore/79, B/Texas/84, and
B/Ann Arbor/86) were grown in 10-day-old embryonated
chicken eggs.
Plasmid construction
All plasmid constructs were based on the cDNA to RNA
segment 7 of influenza B/Lee/40 virus whose cloning and
sequencing has been previously described (Briedis et al.,
1982; Horvath et al., 1990). The BM2 coding region was
cloned from the entire segment 7 coding region by the
polymerase chain reaction (PCR), using Vent DNA poly-
merase (New England Biolabs, Beverley, MA) or Tgo DNA
polymerase (Roche Applied Sciences, Indianapolis, IN).
The modified M2gBM2 and BM2-Flag molecules were
made by standard 4-primer PCR reactions. The eukaryotic
expression vector pCAGGS (Niwa et al., 1991) or pALTER
(Promega Corp., Madison, WI) was used for transient ex-
pression of cDNAs. Details of all cloning steps are available
upon request.
Infection of cells and metabolic radiolabeling
For biochemical experiments MDCK cells in 10-cm
dishes were infected with influenza B/MD/59 virus at a
multiplicity of infection of 5 PFU/ cell. At 7 h postinfection
the cells were washed with DMEM without methionine and
cysteine (DMEM, metcys), incubated in DMEM,
metcys for 30 min, and labeled for 2 h with 150 Ci/ml
Pro-mix L[35S] in vitro cell labeling mix (Amersham Bio-
sciences, Piscataway, NJ). Following the labeling period the
cells were washed with phosphate-buffered saline (PBS)
and scraped off the dishes in 2 ml PBS and pelleted at 466
g for 5 min and stored at 80°C.
Antibodies
Antisera specific for influenza B/Lee/40 BM2 protein
was raised in rabbits using as antigen a SDS-denatured
BM2--galactosidase fusion protein (Horvath et al., 1990).
Antibody to influenza B virus HA was obtained from the
National Institutes of Allergy and Infectious Diseases Influ-
enza Reagent Repository. The MAb 14C2 (M2tag) has been
Fig. 6. Schematic diagram to indicate the conservation of the BM2 TM
domain His and Trp residues as compared to residues in the influenza A
virus M2 proton-selective ion channel protein. Histidine residues are col-
ored red; tryptophan residues are colored green and in BM2 the serine
residues are colored magenta.
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described previously (Zebedee and Lamb, 1988). Anti-Flag
MAb (M2) was obtained from Sigma-Aldrich (St. Louis,
MO).
NaCl and Triton X-100 treatment of cell lysates
The cells from one 10-cm plate of B/MD/59-infected
MDCK cells were resuspended in DHB (20 mM Tris–HCl
pH 7.5, 1 mM MgCl2), Dounce homogenized, and pelleted
at 1000 g. The postnuclear supernatant was divided into 4
and either left untreated, adjusted to 0.5 M NaCl, 2% Triton
X-100, or 0.5 M NaCl  2% Triton X-100 incubated at
25°C for 10 min, and centrifuged at 150,000 g for 30 min at
4°C. The pellet was solubilized in RIPA buffer (0.15 M
NaCl, 1% Na deoxycholate, 1% Triton X-100, 0.1% SDS,
0.01 M Tris–HCl pH 7.4). An equal volume of 2 RIPA
buffer was added to the supernatant and the solubilized
pellet and supernatant were centrifuged at 132,000 g for 10
min and immunoprecipitated with anti-BM2 or anti-B/HA
sera.
Flotation gradient analysis of membrane fractions
A cell homogenate from one 10-cm plate of [35S]methi-
onine/cysteine metabolically labeled influenza B virus-in-
fected MDCK cells was subjected to flotation centrifugation
on Optiprep gradients (density 1.058 to 1.278) essentially as
described (Lindwasser and Resh, 2001) using a Beckman
SW60 rotor (4 h, 4°C, 170,000 g).
Preparation of microsomes and alkali treatment
Isolation of microsomes and treatment of microsomal
membranes with alkali (pH 11.5) was performed as de-
scribed previously (Parks et al., 1989; Paterson and Lamb,
1987). Trypsin treatment of microsomes was performed as
described previously (Paterson and Lamb, 1987).
Transfections
293T, Vero, or HeLa-CD4-LTR--gal cells were trans-
fected with pCAGGS BM2, pCAGGS M2gBM2, pCAGGS
BM2-Flag, or pAlter A/M2 using transfection reagent Trans
IT LT-1 (Panvera, Madison, WI), Effectene (Qiagen, Va-
lencia, CA), or Lipofectamine Plus (Invitrogen, Carlsbad,
CA) according to the manufacturers’ protocols. For meta-
bolical labeling 6-cm-diameter dishes of 293T cells or HeLa
CD4-LTR--gal cells were used. For immunofluorescence
Vero cells or HeLa-CD4-LTR--gal cells were grown on
glass coverslips.
Chemical cross-linking
HeLa-CD4-LTR--gal cells transiently expressing
BM2Flag were 35S-metabolically labeled, removed from the
culture dish, and treated with 0.2% Nonidet P 40 containing
various concentrations of the bifunctional crosslinker
(DTSSP) as described previously (Russell et al., 1994).
Polypeptides were examined by SDS–PAGE on 15% gels.
Immunofluorescence
At 18 h post transfection cell monolayers on coverslips
were fixed with 2% methanol-free formaldehyde for 15 min
and blocked with 1% bovine serum albumin (BSA) or 3%
egg albumin in PBS for 30 min. For intracellular protein
staining, all solutions contained 0.1% saponin (Sigma-Al-
drich) to permeabilize cells. For surface staining cells were
left unpermeabilized. Cells were incubated for 30 min with
appropriate antibodies. Cells were washed four times in
PBS and incubated for 30 min with Alexa Fluor 488 con-
jugated goat anti-mouse IgG secondary antibody (Molecular
Probes Inc., Eugene, OR), FITC-conjugated donkey anti-
mouse IgG secondary antibody, or FITC-conjugated goat
anti-rabbit IgG secondary antibody (Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA). Fluorescence
was observed using a Zeiss LSM 410 confocal microscope
(Zeiss, Inc., Thornwood, NY) and Zeiss software.
Immunoprecipitation of polypeptides and SDS–PAGE
For immunoprecipitation cell pellets or gradient fractions
were adjusted to 1 RIPA buffer containing 0.15 M NaCl,
50 mM iodoacetamide (IAA), 1 mM phenyl-methylsulfonyl
fluoride (PMSF), and protease inhibitors (Paterson and
Lamb, 1993). Lysates were clarified by centrifugation at
132,000 g for 15 min in a Beckman TLA 100.2 rotor and
appropriate antibody aliquots were added to the superna-
tants. After 1–3 h incubation at 4°C immune complexes
were then adsorbed to Protein A–Sepharose beads (Protein
G beads for mouse MAbs) for 30 min at 4°C. The beads
were then washed three times with RIPA  0.3 M NaCl,
twice with RIPA  0.15 M NaCl, and once with 50 mM
Tris (pH 7.4), 0.25 mM EDTA, 0.15 M NaCl. Samples were
then resuspended in SDS–PAGE sample loading buffer
[10% SDS, 1 M Tris (pH 6.8)] containing 2.5% dithiothre-
itol (w/v), boiled, and fractionated by SDS–PAGE on
17.5% gels containing 4 M urea (Lamb and Choppin, 1976).
Visualization and quantification of radiolabeled protein
bands were done using a Fuji BioImager 1000 and Image
Quant v3.3 software (Fuji Medical System, Stamford, CT).
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